Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Modeling and Forecasting of COVID-19 New Cases in the Top 10 Infected African Countries Using Regression and Time Series Models

View ORCID ProfileAlemayehu Siffir Argawu
doi: https://doi.org/10.1101/2020.09.23.20200113
Alemayehu Siffir Argawu
Department of Statistics Ambo University, Ambo, Ethiopia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alemayehu Siffir Argawu
  • For correspondence: alex089973{at}gmail.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background COVID-19 total cases have reached 1,083,071 (83.5%) in the top 10 infected African countries (South Africa, Egypt, Morocco, Ethiopia, Nigeria, Algeria, Ghana, Kenya, Cameroon, and Côte d’Ivoire) from Feb 14 to Sep 6, 2020. Then, this study aimed to model and forecast of COVID-19 new cases in these top 10 infected African countries.

Methods In this study, the COVID 19 new cases data have been modeled and forecasted using curve estimation regression and time series models for these top 10 infected African countries from Feb 14 to Sep 6, 2020.

Results From July to August, the prevalence of COVID-19 cumulative cases was declined in South Africa, Cote d□Ivoire, Egypt, Ghana, Cameron, Nigeria, and Algeria by 31%, 26%, 22%, 20%, 14%, 12%, and 4%, respectively. But, it was highly raised in Ethiopia and Morocco by 41%, and 38% in this period, respectively. In Kenya, it was raised only by 1%. In this study, the cubic regression models for the ln(COVID-19 new cases) data were relatively the best fit for Egypt, Ethiopia, Kenya, Morocco, Nigeria and South Africa. And, the quadratic regression models for the data were the best fit for Cameroon, Cote d□Ivoire and Ghana. The Algeria data was followed the logarithmic regression model. In the time series analysis, the Algeria, Egypt, and South Africa COVID-19 new cases data have fitted the ARIMA (0,1,0), ARIMA (0,1,0), and ARIMA (0,1,14) models, respectively. The Cameroon, Cote d’Ivoire, Ghana, and Nigeria data have fitted the simple exponential smoothing models. The Ethiopia, Kenya, and Morocco data have followed the Damped trend, Holt, and Brown exponential smoothing models, respectively. In the analysis, the trends of COVID-19 new cases will be declined for Algeria and Ethiopia, and the trends will be constantan for Cameroon, Cote d’Ivoire, Ghana and Nigeria. But, it will be raised slightly for Egypt and Kenya, and significantly for Morocco and South Africa from September 7 to October 6, 2020.

Conclusion This study was conducted with the current measures; the forecasts and trends nobtained may differ from the number of cases that occur in the future. Thus, the study finding should be useful in preparedness planning against further spread of the COVID-19 epidemic in African countries. And, the researcher recommended that as many countries continue to relax restrictions on movement and mass gatherings, and more are opening their airspaces, and the countries’ other public and private sectors are reopening. So, strong appropriate public health and social measures must be instituted on the grounds again.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The author received no financial support for the research, authorship, and publication of this article.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

No need of IRB approval.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

In this study, the available data are attained based on the daily reported cases of the WHO, GitHub (owid-COVID-19 data) and Worldometer.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Back to top
PreviousNext
Posted September 24, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Modeling and Forecasting of COVID-19 New Cases in the Top 10 Infected African Countries Using Regression and Time Series Models
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Modeling and Forecasting of COVID-19 New Cases in the Top 10 Infected African Countries Using Regression and Time Series Models
Alemayehu Siffir Argawu
medRxiv 2020.09.23.20200113; doi: https://doi.org/10.1101/2020.09.23.20200113
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Modeling and Forecasting of COVID-19 New Cases in the Top 10 Infected African Countries Using Regression and Time Series Models
Alemayehu Siffir Argawu
medRxiv 2020.09.23.20200113; doi: https://doi.org/10.1101/2020.09.23.20200113

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)